((自动化翻译由路透提供,请见免责声明 ))
路透9月19日 - 美国食品和药物管理局拒绝批准万达制药公司 用于治疗胃麻痹症状的药物,该公司周四表示。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.